Development of Monoclonal Antibodies Targeting Canine PD-L1 and PD-1 and Their Clinical Relevance in Canine Apocrine Gland Anal Sac Adenocarcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of Monoclonal Antibodies Targeting Canine PD-L1 and PD-1 and Their Clinical Relevance in Canine Apocrine Gland Anal Sac Adenocarcinoma
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 24, Pages 6188
Publisher
MDPI AG
Online
2022-12-15
DOI
10.3390/cancers14246188
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ‘Hot Versus Cold’ – Can Transcriptome Analysis of Canine Perianal Tumours Help Illustrate Their Distinct Immunophenotypic Landscapes?
- (2022) A.F.H. Haake et al. JOURNAL OF COMPARATIVE PATHOLOGY
- Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer
- (2022) Daniel Alonso-Miguel et al. Journal for ImmunoTherapy of Cancer
- Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial
- (2022) Federica Riccardo et al. Journal for ImmunoTherapy of Cancer
- PD-L1 as a biomarker of response to immune-checkpoint inhibitors
- (2021) Deborah Blythe Doroshow et al. Nature Reviews Clinical Oncology
- PD-L1 immunohistochemistry for canine cancers and clinical benefit of anti-PD-L1 antibody in dogs with pulmonary metastatic oral malignant melanoma
- (2021) Naoya Maekawa et al. npj Precision Oncology
- Pilot study evaluating the feasibility of stereotactic body radiation therapy for canine anal sac adenocarcinomas
- (2021) Michaela Swan et al. VETERINARY RADIOLOGY & ULTRASOUND
- Prognostic Value of Ki67 and Other Clinical and Histopathological Factors in Canine Apocrine Gland Anal Sac Adenocarcinoma
- (2021) Emanuela Maria Morello et al. Animals
- Evaluation of PD-1 and PD-L1 expression in canine urothelial carcinoma cell lines
- (2021) Christopher J. Pinard et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Minimal late radiation toxicity and transient early toxicity following postoperative definitive intent conformal radiation therapy (20 × 2.5 Gy) for canine apocrine gland anal sac adenocarcinoma
- (2021) Claire Williams et al. VETERINARY RADIOLOGY & ULTRASOUND
- A Retrospective Study of Clinical and Histopathological Features of 81 Cases of Canine Apocrine Gland Adenocarcinoma of the Anal Sac: Independent Clinical and Histopathological Risk Factors Associated with Outcome
- (2021) Hannah Wong et al. Animals
- Evaluation of toceranib for treatment of apocrine gland anal sac adenocarcinoma in dogs
- (2020) Caitlin M. Heaton et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- Recent Findings in the Posttranslational Modifications of PD-L1
- (2020) Shu-Man Li et al. Journal of Oncology
- Assessment of postoperative adjuvant treatment using toceranib phosphate against adenocarcinoma in dogs
- (2020) Hiroki Yamazaki et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- Development of canine PD-1/PD-L1 specific monoclonal antibodies and amplification of canine T cell function
- (2020) Jin Wook Choi et al. PLoS One
- Expression of Phosphorylated Signal Transducer and Activator of Transcription 3 and its Prognostic Significance in Canine Anal Sac Adenocarcinoma
- (2020) Andrea Mosca et al. JOURNAL OF COMPARATIVE PATHOLOGY
- Increased programmed death ligand (PD-L1) and cytotoxic T-lymphocyte antigen-4 (CTLA-4) expression is associated with metastasis and poor prognosis in malignant canine mammary gland tumours
- (2020) Harsha Ariyarathna et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Canine osteosarcoma checkpoint expression correlates with metastasis and T-cell infiltrate
- (2020) Matthew J. Cascio et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
- (2019) Xianjie Jiang et al. Molecular Cancer
- Response and outcome following toceranib phosphate treatment for stage four anal sac apocrine gland adenocarcinoma in dogs: 15 cases (2013–2017)
- (2019) James W. Elliott JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
- Outcome and clinical, pathological, and immunohistochemical factors associated with prognosis for dogs with early-stage anal sac adenocarcinoma treated with surgery alone: 34 cases (2002–2013)
- (2018) Katherine A. Skorupski et al. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
- Prognostic significance of histopathology in canine anal sac gland adenocarcinomas: Preliminary results in a retrospective study of 39 cases
- (2018) J. Pradel et al. Veterinary and Comparative Oncology
- Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody
- (2018) Tadanobu Nagaya et al. Oncotarget
- A Complication Probability Study for a Definitive-intent, Moderately Hypofractionated Image-guided Intensity-modulated Radiotherapy Protocol for Anal Sac Adenocarcinoma in Dogs
- (2018) Valeria Meier et al. Veterinary and Comparative Oncology
- New molecular and therapeutic insights into canine diffuse large B cell lymphoma elucidates the role of the dog as a model for human disease
- (2018) Luca Aresu et al. HAEMATOLOGICA
- Surgical management of primary, metastatic and recurrent anal sac adenocarcinoma in the dog: 52 cases
- (2017) D. C. Barnes et al. JOURNAL OF SMALL ANIMAL PRACTICE
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Safety evaluation of combination carboplatin and toceranib phosphate (Palladia) in tumour-bearing dogs: A phase I dose finding study
- (2017) R. M. Wouda et al. Veterinary and Comparative Oncology
- A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma
- (2017) Naoya Maekawa et al. Scientific Reports
- Immune regulation of canine tumour and macrophage PD-L1 expression
- (2016) G. Hartley et al. Veterinary and Comparative Oncology
- Treatment of advanced canine anal sac adenocarcinoma with hypofractionated radiation therapy: 77 cases (1999-2013)
- (2016) B. McQuown et al. Veterinary and Comparative Oncology
- Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
- (2016) Chia-Wei Li et al. Nature Communications
- Surgical excision of anal sac apocrine gland adenocarcinomas with and without adjunctive chemotherapy in dogs: 42 cases (2005–2011)
- (2015) Christopher P. Potanas et al. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
- Randomized, Placebo-Controlled, Double-Blinded Chemoimmunotherapy Clinical Trial in a Pet Dog Model of Diffuse Large B-cell Lymphoma
- (2013) Laura Marconato et al. CLINICAL CANCER RESEARCH
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Evaluation of adjuvant carboplatin chemotherapy in the management of surgically excised anal sac apocrine gland adenocarcinoma in dogs
- (2013) R. M. Wouda et al. Veterinary and Comparative Oncology
- Preliminary evidence for biologic activity of toceranib phosphate (Palladia®) in solid tumours
- (2011) C. London et al. Veterinary and Comparative Oncology
- Quantitative analysis in spontaneous canine anal sac gland adenomas and carcinomas
- (2008) Radostin Simeonov et al. RESEARCH IN VETERINARY SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started